BOULDER, Colo., Aug. 22, 2012 /PRNewswire/ -- BiOptix today officially announced its fall 2012 Tradeshow and Symposia schedule. These events will highlight the BiOptix Enhanced Surface Plasmon Resonance (ESPR) technology and the forthcoming BiOptix 404pi, a novel and game-changing label-free SPR instrument for kinetic detection. BiOptix Events for fall 2012 include:
- 34th Semiannual Biotechnology Symposia, University of California, San Diego: August 23rd
- HUPO 11th Annual World Congress: September 9 13th
- BioWest 2012: September 11th
- MipTec: September 25 27th
- NIH Research Festival: October 11 12th
- AAPSAmerican Association of Pharmaceutical Scientists: October 14 17th
- 22nd Annual Bristol-Myers Squibb R&D Symposium: October 29 30th
- Label-Free TechnologiesAdvances and Applications: November 1 3rd
- 4th Annual PEGS-Europe Conference: November 6 8th
- Antibody Engineering23rd Annual International Conference: December 2 6th
"BiOptix is excited to be represented at and participate in some of the most prestigious scientific events in Europe and North America for the balance of 2012," noted Ken Wilczek, Vice President of Sales and Marketing for BiOptix. "2012 has been groundbreaking for BiOptix, as we have met with and presented our unique SPR technology to over 3,000 scientific researchers so far. We are enthusiastic to present the BiOptix value proposition to additional scientific researchers in the months ahead."
Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.
BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interactionwith high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com